Injectable Tirzepatide
- Home
- Injectable Tirzepatide
Compounded Tirzepatide is a patient-specific medication prescribed by a licensed healthcare provider following an individualized medical evaluation. It is prepared by a licensed U.S. compounding pharmacy registered under Section 503A or by a 503B FDA-registered outsourcing facility.
Compounded medications are not reviewed or approved by the U.S. Food and Drug Administration (FDA). As such, they may differ from FDA-approved products in terms of safety, effectiveness, quality, and potential side effects. Data from clinical studies on FDA-approved medications should not be assumed to apply to compounded versions.
Patients prescribed injectable tirzepatide receive individualized guidance from a licensed healthcare provider. Each treatment plan is tailored based on medical evaluation, and ongoing monitoring ensures safe and effective use. Patients are encouraged to discuss potential side effects, benefits, and alternative options with their provider to make informed decisions about their weight-management therapy.
Weight Loss MD works exclusively with licensed U.S.-based compounding pharmacies that operate in accordance with applicable federal and state regulations.
What are Compounded Medications?
Compounded medications are not FDA-approved and do not undergo the FDA’s pre-market review process. They may differ from FDA-approved products in terms of safety, effectiveness, risks, and side effects. Clinical trial data from FDA-approved medications should not be assumed to apply to compounded versions.
Weight Loss MD partners exclusively with licensed U.S.-based compounding pharmacies that comply with federal and state regulations.
